6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berco, M; Bhavnani, BR; Cecutti, A; Gerulath, A; Woolever, AC | 1 |
| Blanchfield, JT; Bulmer, AC; Coombes, JS; Fassett, RG; Toth, I | 1 |
2 other study(ies) available for 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
Topics: Analysis of Variance; Antioxidants; Cardiovascular Diseases; Chromans; Estrogens; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Oxidation-Reduction; Postmenopause; Probucol; Progestins; Quercetin; Resveratrol; Thiobarbituric Acid Reactive Substances; Treatment Outcome; Vitamin E; Wine | 2018 |
Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection.
Topics: Adult; Antioxidants; Bilirubin; Cardiovascular Diseases; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Chromans; Copper; Female; Gilbert Disease; Humans; Male; Oxidation-Reduction; Oxygen | 2008 |